Wearable-band type visible-near infrared optical biosensor for non-invasive blood glucose monitoring

Rachim, Vega Pradana; Chung, Wan-Young

doi:10.1016/j.snb.2019.01.121

Cited by 141 publications

(99 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Flexible biosensors demand highly mechanical durability and stability as these devices will be attached to various deformable surfaces. [35][36][37] We first studied the relative electrode resistance change (R n /R 0 ) versus number of bending cycles. The bending radius is about 0.5 cm (Figure 5a).…”

Section: Wwwadvmatinterfacesdementioning

confidence: 99%

High‐Performance Flexible Bioelectrocatalysis Bioassay System Based on a Triphase Interface

Cheng

Zhang

Wang

et al. 2020

Adv Materials Inter

View full text Add to dashboard Cite

Flexible biosensor technologies are essential for the development of noninvasive bioassays such as those based on sweat or interstitial fluid analysis. Cathodic measurement of oxidase catalytic product H2O2 is an ideal principle for analyte detection, with O2 serving as an electron mediator. Herein, the authors report a flexible bioassay system comprising a flexible superhydrophobic polydimethylsiloxane micropillar array substrate, a noble metal H2O2 electrocatalyst‐decorated carbon nanotube film, and an oxidase enzyme top layer. The flexible bioassay system possesses a solid–liquid–air triphase bioelectrocatalysis reaction interface where oxygen levels are air phase dependent, hence constant and sufficient, which enhances and stabilizes the oxidase kinetics. In comparison with conventional flexible diphase bioassay systems, when used for analyte detection including but are not limited to glucose, choline, and lactate in body fluids, the triphase bioassay system displays a wide linear dynamic range and high selectivity. Moreover, the flexible bioassay system remains intact and fully operational after being bent over 500 times. Such a system should greatly promote the development of noninvasive biosensors for the monitoring of physiological biomarkers.

show abstract

Section: Wwwadvmatinterfacesdementioning

confidence: 99%

High‐Performance Flexible Bioelectrocatalysis Bioassay System Based on a Triphase Interface

Cheng

Zhang

Wang

et al. 2020

Adv Materials Inter

View full text Add to dashboard Cite

show abstract

“…On other hand, using dermal biosensors to control glucose levels is a novel technique that allows the measurement of blood levels to be a non-intrusive technology for patients. This new method is based on a band that is placed on the wrist; through combined near-visible infrared spectroscopy (Vis-NIR), it allows the measurement of glucose found mainly in arterial blood [177].…”

Section: Total Internal Reflection Fluorescence (Tirf) Biosensorsmentioning

confidence: 99%

Optical Biosensors for Therapeutic Drug Monitoring

et al. 2019

View full text Add to dashboard Cite

Therapeutic drug monitoring (TDM) is a fundamental tool when administering drugs that have a limited dosage or high toxicity, which could endanger the lives of patients. To carry out this monitoring, one can use different biological fluids, including blood, plasma, serum, and urine, among others. The help of specialized methodologies for TDM will allow for the pharmacodynamic and pharmacokinetic analysis of drugs and help adjust the dose before or during their administration. Techniques that are more versatile and label free for the rapid quantification of drugs employ biosensors, devices that consist of one element for biological recognition coupled to a signal transducer. Among biosensors are those of the optical biosensor type, which have been used for the quantification of different molecules of clinical interest, such as antibiotics, anticonvulsants, anti-cancer drugs, and heart failure. This review presents an overview of TDM at the global level considering various aspects and clinical applications. In addition, we review the contributions of optical biosensors to TDM.

show abstract

“…The biosensor will satisfy the need of diabetic patients when the biosensor consists of following properties like durable, easy to use, and higher in sensitivity and long term stability Artificial intelligence and biological sciences can come together to develop the more efficient non-invasive sensor for glucose monitoring. The biosensor is a special purpose transducer which converts biological data into an electrical signal [1][2][3][4][5][6][7]. Table no 1 shows different biosensor and their future scopes.…”

Section: A Recent Sensor Technology For Glucose Monitoringmentioning

confidence: 99%

“…Sensor technology plays a significant role in this area, which works on the concept of Biological mechanism. This biosensor uses different media for analysis like Interstitial Fluid (ISF), sweat, tears Saliva and many other [1][2][3][4][5][6][7]. Another basic area where Artificial intelligence can provide a unique solution is in terms of estimating diabetic patient's carbohydrate intakes monitoring.…”

Section: Introductionmentioning

confidence: 99%

Refining Healthcare in Terms of Diabetic Care: Future Area of Scope for Artificial Intelligence

2019

IJRTE

View full text Add to dashboard Cite

Recently, the entire world is facing another noncommunicable disease known as Diabetics. Basic reasons behind this disease is not unique , but certainly may be due to an increase in economic burden, less activity, change in lifestyle, improper food intake and increase in the level of stress. This disease has its effects all over the ages in the world from child to old age people. Hence its treatment is a big challenge to the social and economic growth of every nation. Plenty of research is undergoing in this area to improve health care which requires certain modifications and validations by clinical trials. Advancement in artificial intelligence is able to provide unique solutions in the future. The basic motivation behind this paper is to study the entire innovation taking place in recent years in the area of diabetic prevention and detection. Continuous monitoring of blood glucose level by invasive and non-invasive sensor technology, diet monitoring system, activity monitoring, intelligent foot and artificial pancreas for diabetics is the major focus of this study. Also, these studies focus on complete medical healthcare solution by using artificial intelligence. This study will surely help to identify future scope in the area of diabetic and its prevention models which can act as a future of diabetic health care

show abstract

Wearable-band type visible-near infrared optical biosensor for non-invasive blood glucose monitoring

Cited by 141 publications

References 35 publications

High‐Performance Flexible Bioelectrocatalysis Bioassay System Based on a Triphase Interface

High‐Performance Flexible Bioelectrocatalysis Bioassay System Based on a Triphase Interface

Optical Biosensors for Therapeutic Drug Monitoring

Refining Healthcare in Terms of Diabetic Care: Future Area of Scope for Artificial Intelligence

Contact Info

Product

Resources

About